Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 139

1.

Underestimation of the efficacy, effectiveness, tolerability, and safety of weekly low-dose methotrexate in information presented to physicians and patients.

Pincus T, Furer V, Sokka T.

Clin Exp Rheumatol. 2010 Sep-Oct;28(5 Suppl 61):S68-79. Epub 2010 Oct 28. Review.

PMID:
21044437
[PubMed - indexed for MEDLINE]
2.

Long-term safety of methotrexate in the treatment of rheumatoid arthritis.

Yazici Y.

Clin Exp Rheumatol. 2010 Sep-Oct;28(5 Suppl 61):S65-7. Epub 2010 Oct 28. Review.

PMID:
21044436
[PubMed - indexed for MEDLINE]
3.

Update on methotrexate as the anchor drug for rheumatoid arthritis.

Pincus T, Gibson KA, Castrejón I.

Bull Hosp Jt Dis (2013). 2013;71 Suppl 1:S9-19. Review.

PMID:
24219036
[PubMed - indexed for MEDLINE]
Free Article
4.

Methotrexate as the "anchor drug" for the treatment of early rheumatoid arthritis.

Pincus T, Yazici Y, Sokka T, Aletaha D, Smolen JS.

Clin Exp Rheumatol. 2003 Sep-Oct;21(5 Suppl 31):S179-85. Review.

PMID:
14969073
[PubMed - indexed for MEDLINE]
5.

Infliximab and methotrexate in the treatment of rheumatoid arthritis: a systematic review and meta-analysis of dosage regimens.

Zintzaras E, Dahabreh IJ, Giannouli S, Voulgarelis M, Moutsopoulos HM.

Clin Ther. 2008 Nov;30(11):1939-55. doi: 10.1016/j.clinthera.2008.11.007. Review.

PMID:
19108784
[PubMed - indexed for MEDLINE]
6.

The clinical and cost-effectiveness of anakinra for the treatment of rheumatoid arthritis in adults: a systematic review and economic analysis.

Clark W, Jobanputra P, Barton P, Burls A.

Health Technol Assess. 2004 May;8(18):iii-iv, ix-x, 1-105. Review.

PMID:
15130461
[PubMed - indexed for MEDLINE]
Free Article
7.

Methotrexate in rheumatoid arthritis.

Swierkot J, Szechiński J.

Pharmacol Rep. 2006 Jul-Aug;58(4):473-92. Review.

PMID:
16963793
[PubMed - indexed for MEDLINE]
Free Article
8.

[Reducing toxicity of methotrexate with folic acid].

Harten P.

Z Rheumatol. 2005 Jun;64(5):353-8. German.

PMID:
15965822
[PubMed - indexed for MEDLINE]
9.

Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review and economic evaluation.

Woolacott N, Bravo Vergel Y, Hawkins N, Kainth A, Khadjesari Z, Misso K, Light K, Asseburg C, Palmer S, Claxton K, Bruce I, Sculpher M, Riemsma R.

Health Technol Assess. 2006 Sep;10(31):iii-iv, xiii-xvi, 1-239. Review.

PMID:
16948890
[PubMed - indexed for MEDLINE]
Free Article
10.

Comparison of two schedules for administering oral low-dose methotrexate (weekly versus every-other-week) in patients with rheumatoid arthritis in remission: a twenty-four week, single blind, randomized study.

Luis M, Pacheco-Tena C, Cazarín-Barrientos J, Lino-Pérez L, Goycochea MV, Vazquez-Mellado J, Burgos-Vargas R.

Arthritis Rheum. 1999 Oct;42(10):2160-5.

PMID:
10524688
[PubMed - indexed for MEDLINE]
Free Article
11.

Use of methotrexate in older patients. A risk-benefit assessment.

Tett SE, Triggs EJ.

Drugs Aging. 1996 Dec;9(6):458-71.

PMID:
8972245
[PubMed - indexed for MEDLINE]
12.

Methods to enhance the safety of methotrexate prescribing.

Goldsmith P, Roach A.

J Clin Pharm Ther. 2007 Aug;32(4):327-31. Erratum in: J Clin Pharm Ther. 2007 Oct;32(5):534.

PMID:
17635334
[PubMed - indexed for MEDLINE]
13.

[Methotrexate therapy in rheumatologic diseases--an update].

Cauza E, Dunky A.

Wien Med Wochenschr. 2003;153(13-14):291-4. Review. German.

PMID:
12924103
[PubMed - indexed for MEDLINE]
14.

[Methotrexate and folates in rheumatoid arthritis].

Endresen GK, Husby G.

Tidsskr Nor Laegeforen. 1999 Feb 10;119(4):534-7. Review. Norwegian.

PMID:
10081378
[PubMed - indexed for MEDLINE]
15.

Clinical pharmacokinetics of low-dose pulse methotrexate in rheumatoid arthritis.

Bannwarth B, Péhourcq F, Schaeverbeke T, Dehais J.

Clin Pharmacokinet. 1996 Mar;30(3):194-210. Review.

PMID:
8882301
[PubMed - indexed for MEDLINE]
16.

Folate supplementation during methotrexate therapy for rheumatoid arthritis.

Morgan SL, Baggott JE.

Clin Exp Rheumatol. 2010 Sep-Oct;28(5 Suppl 61):S102-9. Epub 2010 Oct 28. Review.

PMID:
21044441
[PubMed - indexed for MEDLINE]
17.

Toward a definition and method of assessment of treatment failure and treatment effectiveness: the case of leflunomide versus methotrexate.

Wolfe F, Michaud K, Stephenson B, Doyle J.

J Rheumatol. 2003 Aug;30(8):1725-32.

PMID:
12913927
[PubMed - indexed for MEDLINE]
18.

Evidence-based use of methotrexate in children with rheumatic diseases: a consensus statement of the Working Groups Pediatric Rheumatology Germany (AGKJR) and Pediatric Rheumatology Austria.

Niehues T, Horneff G, Michels H, Höck MS, Schuchmann L; Working Groups Pediatric Rheumatology Germany (AGKJR); Pediatric Rheumatology Austria.

Rheumatol Int. 2005 Apr;25(3):169-78. Epub 2005 Feb 2.

PMID:
15688190
[PubMed - indexed for MEDLINE]
19.

The treatment of inflammatory arthritis with methotrexate in clinical practice: treatment duration and incidence of adverse drug reactions.

Kinder AJ, Hassell AB, Brand J, Brownfield A, Grove M, Shadforth MF.

Rheumatology (Oxford). 2005 Jan;44(1):61-6.

PMID:
15611303
[PubMed - indexed for MEDLINE]
Free Article
20.

The use of methotrexate in children with rheumatic diseases.

Gutiérrez-Suárez R, Burgos-Vargas R.

Clin Exp Rheumatol. 2010 Sep-Oct;28(5 Suppl 61):S122-7. Epub 2010 Oct 28.

PMID:
21044445
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk